Please search for your last name

no photo
Hospital Universitari de Bellvitge
Internal Medicine
no photo
Klinukim der Universität München
Institute of Cardiovascular Prevention
no photo
Ukrainian Military Medical Academy
Department of Aviation Marine Medicine
no photo
AUSL - IRCCS REGGIO EMILIA
DIAGNOSTIC IMAGING AND LABORATORY MEDICINE
no photo
Medical University Vienna
Department of Internal Medicine III, Division of Endocrinology and Metabolsim
University of Cambridge
Centre for Naturally Randomized Trials, School of Clinical Medicine
Brian is a cardiologist and genetic epidemiologist who was educated and trained at Harvard, Yale, Oxford and Cambridge Universities. He graduated from Yale Medical School and trained as a clinical investigator resident in Internal Medicine and as a special student in clinical epidemiology and genetic epidemiology as part of the Robert Wood Johnson Clinical Scholars Program at Yale. He then trained in cardiology and interventional cardiology at Harvard Medical School. While at Harvard, he also completed the Program in Clinical Effectiveness at Harvard School of Public Health, and was an NHLBI Cardiovascular (Genetic) Epidemiology Fellow at the Brigham and Women’s Hospital and Harvard Medical School. He then earned a business degree from the University of Cambridge, and a degree in evidence-based medicine with a focus on clinical trial design from the University of Oxford He is currently Professor and Director of Research in Translational Therapeutics, and Head of the Centre for Naturally Randomized Trials at the University of Cambridge, UK. His previous positions included Chief of Cardiology at a US University; Chief Medical and Scientific Officer for a public-private collaboration working on the Chinese Precision Medicine Initiative in Beijing; and CEO of a biotechnology company.
no photo
Ospedale Vito Fazzi
Nephrology, Dialysis and Transplantation
no photo
Nuestra Señora de Candelaria Hospital
Research unit
no photo
Universitá degli Studi di Padova
Dipartimento di Medicina
no photo
FSBO National Medical Research Center of Cardiology of Russian Ministry of Health
Laboratory of Cell Immunology
no photo
AORN Dei Colli
Centro Ricerche Cardiologia SUN Piano Terra
no photo
University of Bologna
Medical and Surgical Sciences Department
no photo
Università degli Studi di Milano
Department of Pharmacological and biomolecular sciences
no photo
Copenhagen University Hospitalet - Rigshospitalet; University of Copenhagen
Department of Clinical Biochemistry
Ruth Frikke-Schmidt is professor at the University of Copenhagen and Chief Physician at Rigshospitalet, Copenhagen, Denmark. She has been Chairman of the Scandinavian Society for Atherosclerosis Research (SSAR), and has been member of the EAS Executive Committee. She is a member of steering committees for the Copenhagen General Population Study, the Copenhagen Baby Heart Study, and the European Alzheimer & Dementia Biobank. She is serving as chair of the EAS Award Committee and was chairman of the Scientific Programme Committee for the EAS 2020 Congress. She has contributed to and organized EAS Advanced Courses. Early on RFS performed a series of papers on central lipid transport proteins, apoE and ABCA1. By using a series of genetic strategies in large general population samples, novel concepts for understanding common and rare genetic variants in lipid metabolism were generated. The work from her and her colleagues on the genetic background for HDL cholesterol had major impact on drug-development in the field. Subsequently, she leveraged her knowledge from peripheral lipid metabolism into neurodegenerative diseases, where local lipid transport is emerging as a key player. The Frikke-Schmidt group established apoE levels as causal factors for dementia in large scale genotyping and resequencing efforts and developed a 10-year absolute risk score for dementia which illustrated the substantial impact of preventable/treatable cardiovascular risk factors for risk of dementia.
no photo
Kurume Univiersity School of Medicine
Division of Cardiovascular Medicine, Department of Internal Medicine
Spanish National Center for Cardiovascular Disease (CNIC)
Hematovascular Pathophysiology Laboratory
José Fuster is Assistant Professor and Group Leader at the Spanish National Center for Cardiovascular Research (CNIC) in Madrid (Spain). Previously, he completed postdoctoral training at Boston University School of Medicine in the USA and held faculty positions at Boston University (2015-2018) and the University of Virginia (2018). At CNIC he leads a research group focused on the investigation of the interplay between aging, hematopoiesis and cardiovascular disease, with a particular interest in the pathophysiology of atherosclerosis and heart failure. He is considered a leading expert in the role of age-related clonal hematopoiesis in cardiovascular disease and he actively collaborates on this topic with several international research groups. His work on this topic has been published in prestigious journals, including research articles in Science, the Journal of the American College of Cardiology and Cell Reports. Among other awards, he has been awarded the Young Investigator Award of the European Atherosclerosis Society.